multivitamin: Clinical Trials

4 trials of multivitamin, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 completed, 1 recruiting, 1 unknown. 4 Phase 1, 2 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 14Completed 2, Recruiting 1, Unknown 1
Phase 22Completed 1, Unknown 1

Follow multivitamin: new trials by email Literature Review of multivitamin trials Research Report on multivitamin

Trials (filtered) newest first · largest first

All 4 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Pre-emptive Pregabalin on Attenuating Maternal Anxiety And Stress Response To Intubation During Caesarean Section
Pregabalin 150mg, multivitamin - Anxiety State, Sedation
Phase 1 / Phase 2UnknownZagazig University742020-11-152021-02-04
Edetate Calcium Disodium or Succimer in Treating Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome Undergoing Chemotherapy
Edetate Calcium Disodium, Multivitamin, Succimer - Acute Myeloid Leukemia, Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome
Phase 1RecruitingM.D. Anderson Cancer Center582018-10-112026-09-18
Pre-operative IRX-2 in Early Stage Breast Cancer (ESBC)
Cyclophosphamide, Indomethacin, Omeprazole - Breast Neoplasm, Breast Neoplasm, Male
Phase 1CompletedProvidence Health & Services162017-02-092025-12-03
Kuvan in People With Schizophrenia and Schizoaffective Disorder
Kuvan, Multivitamin - Schizophrenia, Schizoaffective Disorder
Phase 1 / Phase 2CompletedNew York State Psychiatric Institute272012-10-012017-09-13

Conditions studied

Anxiety Disorders (1)  ·  Blast Crisis (1)  ·  Breast Neoplasms (1)  ·  Breast Neoplasms, Male (1)  ·  Leukemia, Myelogenous, Chronic, BCR-ABL Positive (1)  ·  Leukemia, Myeloid, Acute (1)  ·  Myelodysplastic Syndromes (1)  ·  Myelodysplastic-Myeloproliferative Diseases (1)  ·  Myeloproliferative Disorders (1)  ·  Psychotic Disorders (1)  ·  Schizophrenia (1)  ·  Triple Negative Breast Neoplasms (1)

Sponsors

M.D. Anderson Cancer Center (1)  ·  New York State Psychiatric Institute (1)  ·  Providence Health & Services (1)  ·  Zagazig University (1)

Countries

United States (3)  ·  Egypt (1)

Top investigators

David Page, MD (1)  ·  Jeffrey A Lieberman, M.D. (1)  ·  Maro Ohanian (1)  ·  Sara Abdel Naby, M.D (1)

Results publications

PMID 33413574